These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 6284362)

  • 21. Results of treatment with an intensive combination induction regimen containing idarubicin in children with acute myeloblastic leukemia: preliminary report of the Argentine Group for Treatment of Acute Leukemia.
    Sackmann-Muriel F; Fernández-Barbieri MA; Santarelli MT; Matus-Ridley M; Rosso A; Negri-Aranguren P; Cerutti I; Gomel M; Kvicala R
    Semin Oncol; 1993 Dec; 20(6 Suppl 8):34-8. PubMed ID: 8290970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase I and early phase II study of PL-AC [N4-palmitoyl-(1-beta-D-arabinofuranosyl) cytosine] on hematopoietic malignancies.
    Takubo T; Tani Y; Kubota Y; Oguma S; Ueda T; Nakamura H; Shibata H; Masaoka T
    Nihon Gan Chiryo Gakkai Shi; 1984 Feb; 19(1):1-7. PubMed ID: 6597236
    [No Abstract]   [Full Text] [Related]  

  • 23. Phase II study of amsacrine gluconate in refractory leukemia.
    Omura GA; Winton EF; Vogler WR; Zuckerman KS; Grillo-Lopez AJ
    Cancer Treat Rep; 1983 Dec; 67(12):1131-2. PubMed ID: 6580948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II trial of zinostatin in children with late-stage acute lymphocytic leukemia: a Pediatric Oncology Group Study.
    Sexauer C; Kim T; Nix W; Berry DH; Morgan S
    Cancer Treat Rep; 1981; 65(1-2):173-4. PubMed ID: 6452947
    [No Abstract]   [Full Text] [Related]  

  • 25. A phase II clinical trial of peptichemio. Clinical screening cooperative group of European Organisation on Research on Treatment of Cancer (E.O.R.T.C).
    Biomedicine; 1977 Nov; 27(8):290-4. PubMed ID: 339970
    [No Abstract]   [Full Text] [Related]  

  • 26. Therapeutic results: report of the Hungarian children's leukaemia study group.
    Schuler D; Gálfi I; István L; Kassai P; Kemény P; Laub MW; Romhányi J; Székely K; Velkey L; Virág I; Zimonyi I
    Haematologia (Budap); 1976; 10(1):51-6. PubMed ID: 1070467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II trial of amsacrine in patients with hepatoma: a Cancer and Leukemia Group B study.
    Amrein PC; Richards F; Coleman M; Poulin RF; Holland JF; Weinberg V; Perry M
    Cancer Treat Rep; 1984 Jun; 68(6):923-4. PubMed ID: 6329510
    [No Abstract]   [Full Text] [Related]  

  • 28. [Long-term prognosis in 139 children with acute lymphoblastic leukemia in complete remission for longer than three years--study of Children's Cancer and Leukemia Study Group].
    Fujimoto T; Sasaki K; Oomochi Y; Kawai S; Fujimoto T; Mimaya J; Yatabe M; Hiyoshi Y; Tanaka K; Koizumi S
    Rinsho Ketsueki; 1987 Feb; 28(2):177-86. PubMed ID: 3471985
    [No Abstract]   [Full Text] [Related]  

  • 29. Phase II evaluation of diglycoaldehyde (Inox) in children with acute leukemia: a children's cancer study group report.
    Higgins GR; Finklestein J; Krivit W; Hammond D
    Cancer Treat Rep; 1980; 64(4-5):625-8. PubMed ID: 7427952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Observations on toxicity and clinical trials with daunomycin.
    Serpick AA; Henderson ES
    Pathol Biol; 1967 Oct; 15(19):909-12. PubMed ID: 4967536
    [No Abstract]   [Full Text] [Related]  

  • 31. Prednimustine in elderly patients with multiple myeloma: a phase II study.
    Tirelli U; Sorio R; Magri MD; Zagonel V; Vaccher E; Carbone A; Trovò M; Grigoletto E
    Cancer Treat Rep; 1986 Apr; 70(4):537-8. PubMed ID: 3698051
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prednimustine in treatment of acute leukemia in elderly patients].
    Brandt L; Könyves I
    Lakartidningen; 1977 Apr; 74(15):1490-3. PubMed ID: 321896
    [No Abstract]   [Full Text] [Related]  

  • 33. Prednimustine in advanced malignant melanoma: a phase II study.
    Pedersen L; Løber J; Dalmark M; Mouridsen HT
    Cancer Treat Rep; 1987 Dec; 71(12):1315-6. PubMed ID: 3690549
    [No Abstract]   [Full Text] [Related]  

  • 34. Phase I trial of mitoxantrone in children.
    Ungerleider RS; Pratt CB; Vietti TJ; Holcenberg JS; Kamen BA; Glaubiger DL; Cohen LF
    Cancer Treat Rep; 1985 Apr; 69(4):403-7. PubMed ID: 3857968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prednimustine in adult acute myeloid leukaemia.
    Brandt L; Könyves I
    Cancer Chemother Pharmacol; 1979; 2(2):133-6. PubMed ID: 394873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination chemotherapy with amsacrine (AMSA) and cyclocytidine in refractory childhood leukemia: preliminary observations of a phase II study.
    Miller LP; Miller DR; Tan CT
    Cancer Treat Rep; 1983 May; 67(5):439-43. PubMed ID: 6189604
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of refractory chronic lymphocytic leukemia with prednimustine: a phase II study using strict response criteria.
    Gandara DR; George CB; Ries CA; Koretz MM; Lewis JP
    Cancer Chemother Pharmacol; 1987; 19(2):165-8. PubMed ID: 3568275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A phase III study of prednimustine (LEO 1031) in advanced breast cancer. A preliminary report.
    Rørth M; Løber J; Dombernowsky P; Krusenstjerna-Hofstrom D; Mattsson W; Mouridsen HT
    Eur J Cancer (1965); 1980; Suppl 1():137-40. PubMed ID: 7032923
    [No Abstract]   [Full Text] [Related]  

  • 39. [L-asparaginase in the treatment of acute leukoses].
    Storti E; Fontana G; Ascari E; Lusvarghi E; Silingardi V; Quaglino D; Sgandurra A; Barbieri U; Traldi A
    Minerva Med; 1970 Sep; 61(71):3635-42. PubMed ID: 5271737
    [No Abstract]   [Full Text] [Related]  

  • 40. Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study.
    Blaney SM; Needle MN; Gillespie A; Sato JK; Reaman GH; Berg SL; Adamson PC; Krailo MD; Bleyer WA; Poplack DG; Balis FM
    Clin Cancer Res; 1998 Feb; 4(2):357-60. PubMed ID: 9516923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.